Global injectable thyroid drug market is anticipated to grow at a CAGR of 5.9% during the forecast period (2024-2031). Thyroid disease tests and diagnoses are expected to rise in tandem with growing public awareness of thyroid treatment options. This growing number of thyroid prevalence offers businesses the chance to spend money on R&D to create new, more […]
